NHI
National Health Investors Inc
64.90$
+0.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.0% | 67.0% | 50.3% | 71.8% | 58.6% | 67.1% | 52.5% | 67.7% | 69.7% | 65.1% | 46.1% | 53.9% | 57.9% | |
| 21.9% | 21.5% | 22.4% | 21.4% | 22.3% | 22.6% | 22.3% | 22.8% | 22.5% | 21.0% | 21.1% | 21.1% | 21.3% | |
| 1.1% | 1.1% | 2.6% | 0.8% | 0.8% | 0.8% | 2.9% | 1.2% | 1.1% | 904.8% | 1.9% | 3.8% | 224.1% | |
| 0.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.9% | 5.9% | -14.2% | 8.1% | -2.7% | 5.1% | -10.3% | 4.9% | 0.3% | 11.0% | -8.7% | 2.0% | 1.0% | |
| 3.2% | 1.5% | 2.8% | 3.2% | 5.6% | 7.0% | 2.4% | 2.9% | 5.6% | 9.5% | 2.5% | 2.4% | 4.8% | |
| -24.9% | 2.9% | -20.1% | -15.9% | -1.9% | -186.7% | -85.0% | -54.9% | 46.6% | -175.7% | -89.7% | -35.8% | -67.5% | |
| 48.8% | 49.2% | 47.9% | 46.0% | 47.1% | 45.8% | 46.0% | 46.4% | 47.6% | 41.1% | 38.4% | 36.7% | 40.5% | |
| 0.0% | 0.0% | – | -0.5% | -6.5% | 166.0% | 73.3% | 136.2% | 150.2% | 170.4% | – | – | – | |
| 11.1% | – | – | – | -0.7% | 14.1% | 129.8% | -159.8% | -7.6% | 50.7% | 90.6% | 3.3% | 36.0% | |
| -38.1% | -62.2% | -44.1% | -51.6% | -55.7% | 129.7% | 156.5% | -142.9% | -46.9% | 52.4% | 48.1% | 3.2% | 16.9% | |
| -1.0% | 7.7% | -13.5% | 4.0% | 1.0% | 10.2% | 124.1% | -128.3% | 70.1% | -58.2% | 4.6% | 21.4% | 7.4% | |
| 62.0% | 65.5% | 47.5% | 68.5% | 53.0% | 60.1% | 50.1% | 64.8% | 64.1% | 55.6% | 43.6% | 56.3% | 54.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.